Technology for smoke-free surgery helps Alesi Surgical raise €6m

Alesi Surgical Limited, which develops technology solutions for minimally invasive surgery technologies, has received new investment from Panakes Partners and Earlybird, plus support from existing shareholders IP Group and Finance Wales.

The company has developed Ultravision, which is the world’s first technology to use electrostatic technology to clear the vapour and particulate matter – so called “surgical smoke” – that is generated by modern surgical cutting instruments during abdominal laparoscopic surgery.

Thom Rasche, partner at Earlybird, said: “Obscuring of the surgical view during the laparoscopic procedure is not only cumbersome to surgeons but adds an additional risk to the safety of the procedure and to the staff being exposed to the smoke. Alesi has developed a fabulous, simple and very effective solution to help address these risks.”

In use, the medical device produces a low-energy electrostatic charge and improves visibility for surgeons by eliminating surgical smoke as it is created by the cutting instrument. Minimising exposure to surgical smoke is said to be increasingly important because of concerns over the health risks associated with long-term exposure.